Although IL-7/IL-15-treated polyclonal T cells have less differentiation and more anti-tumor efficiency, they either show no significant T cell [19] expansion advantage or a small T cell [20] and CAR T cell expansion [21, 22] compared to IL-2 only-treated cells. This evidence concerns the gene IL7 and neoplasm.